"Franciscan Physician Network Oncology & Hematology Specialists in Indianapolis has been recognized for meeting the highest standards for quality cancer care."

During the past decade, St. Francis Medical Group Oncology and Hematology Specialists conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Francis Medical Group Oncology and Hematology Specialists" #1 sponsor was "Seagen Inc." with 2 trials, followed by "BioSight Ltd." with 1 trials sponsored, "Cyclacel Pharmaceuticals, Inc." with 1 trials sponsored, "Jazz Pharmaceuticals" with 1 trials sponsored and "Lexicon Pharmaceuticals" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Francis Medical Group Oncology and Hematology Specialists" #1 collaborator was "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "St. Francis Medical Group Oncology and Hematology Specialists" are "Acute Myeloid Leukemia" (3 trials), "Disease, Hodgkin" (2 trials), "Lymphoma, Large-Cell, Anaplastic" (2 trials), "Lymphoma, Non-Hodgkin" (2 trials) and "Acute Myeloid Leukemia With Myelodysplasia-Related Changes" (1 trials). Many other conditions were trialed in "St. Francis Medical Group Oncology and Hematology Specialists" in a lesser frequency.

Most popular intervention types in "St. Francis Medical Group Oncology and Hematology Specialists" are "Drug" (7 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "brentuximab vedotin" (2 trials), "BST-236" (1 trials), "CPX-351" (1 trials), "Decitabine" (1 trials) and "Lucanix™" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Francis Medical Group Oncology and Hematology Specialists" are 8 trials for "All" genders.

Currently, there are NaN active trials in "St. Francis Medical Group Oncology and Hematology Specialists". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in St. Francis Medical Group Oncology and Hematology Specialists, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St. Francis Medical Group Oncology and Hematology Specialists, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".